Adaptive Biotechnologies (ADPT) Long-Term Investments (2019 - 2026)

Adaptive Biotechnologies (ADPT) has 7 years of Long-Term Investments data on file, last reported at $18.9 million in Q1 2026.

• Quarterly Long-Term Investments fell 52.0% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (down 52.0% YoY) and the FY2025 annual result came in at $13.2 million, down 60.68% from the prior year.
• Long-Term Investments climbed to $18.9 million in Q1 2026 per ADPT's latest filing, from $13.2 million in the prior quarter.
• The five-year high for Long-Term Investments was $137.1 million in Q1 2022, with the low at $4.0 million in Q3 2025.
• Average Long-Term Investments over 4 years is $38.1 million, with a median of $24.0 million recorded in 2024.
• The widest YoY moves for Long-Term Investments: up 346.79% in 2022, down 90.94% in 2022.
• Adaptive Biotechnologies' Long-Term Investments stood at $19.7 million in 2022, then surged by 70.88% to $33.7 million in 2024, then slumped by 60.68% to $13.2 million in 2025, then jumped by 42.73% to $18.9 million in 2026.
• Business Quant data shows ADPT's Long-Term Investments at $18.9 million in Q1 2026, $13.2 million in Q4 2025, and $4.0 million in Q3 2025.